$4.04 -$0.03 (-0.7%)

12:47 PM EDT on 07/18/19

Hemispherx Biopharma Inc (NYSEMKT:HEB)

CAPS Rating: 1 out of 5

A biopharmaceutical company engaged in the clinical development, manufacture, marketing and distribution of new drug entities based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders.

Current Price $4.04 Mkt Cap $9.03
Open $4.24 P/E Ratio 0.00
Prev. Close $4.07 Div. (Yield) $0.00 (0.0%)
Daily Range $4.01 - $4.24 Volume 6,831
52-Wk Range $3.65 - $14.61 Avg. Daily Vol. 26

Caps

How do you think NYSEMKT:HEB will perform against the market?

Add Stock to CAPS Watchlist

All Players

105 Outperform
85 Underperform
 

All-Star Players

11 Outperform
33 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NYSEMKT:HEB Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

BioPharmacist (< 20)
Submitted December 12, 2012

Gonna surprise everyone with an advisory committee panel that votes in favor of accelerated approval with phase 4 trials being required.

TrendIsMyFriend (< 20)
Submitted December 07, 2006

Ok where should I start?To my knowledge:The company burns more then 4 mil $$$ each quarter.They have just couple products.Ampligen®Alferon LDO®which have high side effects chance and at best they can sell those products for 6milThey have couple more… More

NYSEMKT:HEB VS S&P 500 (SPY)

Fools bullish on NYSEMKT:HEB are also bullish on:

Fools bearish on NYSEMKT:HEB are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about HEB.

Recs

0
Member Avatar SmartAce (99.97) Submitted: 6/24/2019 11:24:54 AM : Underperform Start Price: $3.90 NYSE MKT:HEB Score: -2.48

Everybody knows that if you stand in front of a mirror and brush the stomach part of your shirt three times then it hides how you actually look for the rest of the day.

Recs

1
Member Avatar BioPharmacist (< 20) Submitted: 12/12/2012 1:48:29 AM : Outperform Start Price: $8.40 NYSE MKT:HEB Score: -158.63

Gonna surprise everyone with an advisory committee panel that votes in favor of accelerated approval with phase 4 trials being required.

Recs

0
Member Avatar SnarkyApple (24.56) Submitted: 9/18/2012 12:51:34 PM : Underperform Start Price: $9.59 NYSE MKT:HEB Score: +161.08

Shenanigans.

Leaderboard

Find the members with the highest scoring picks in HEB.

Score Leader

TMFBiologyFool

TMFBiologyFool (77.96) Score: +332.54

The Score Leader is the player with the highest score across all their picks in HEB.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
RetestingLows 27.46 7/9/2009 Underperform 5Y $25.56 -84.19% +238.14% +322.33 0 Comment
marginaddict < 20 6/23/2009 Underperform 3W $25.56 -84.19% +234.30% +318.49 3 Comments
thestockstalker < 20 5/21/2009 Underperform NS $21.60 -81.30% +236.23% +317.53 0 Comment
soul2197 25.51 6/25/2009 Underperform 3W $22.68 -82.19% +233.58% +315.76 0 Comment
GingerBean < 20 6/26/2009 Underperform 5Y $28.32 -85.73% +225.95% +311.68 0 Comment
ehabob 79.41 5/28/2009 Underperform 3M $20.64 -80.43% +230.62% +311.04 0 Comment
raambo < 20 6/3/2009 Underperform 3W $30.24 -86.64% +223.76% +310.40 0 Comment
avatre < 20 6/8/2009 Underperform 5Y $35.88 -88.74% +220.53% +309.27 0 Comment
Hero4All 29.41 5/20/2009 Underperform 5Y $21.36 -81.09% +227.86% +308.95 0 Comment
dannyboy124 28.49 6/15/2009 Underperform 5Y $34.20 -88.19% +220.10% +308.29 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackBoenning < 20 12/5/2006 Outperform NS $25.80 -83.81% -1.70% -82.12 4/17/2012 @ $4.18 0 Comment

Advertisement